Cargando…
Expert Perspectives on the Vaccination of Individuals Who Are at Increased Risk of Meningococcal Disease Due to Medical Conditions: A Podcast
Patients with functional or anatomic asplenia, including sickle cell anemia; complement component deficiency; or human immunodeficiency virus (HIV) infection have a significantly increased risk of developing meningococcal disease. The Advisory Committee on Immunization Practices (ACIP) of the Center...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10147888/ https://www.ncbi.nlm.nih.gov/pubmed/36913178 http://dx.doi.org/10.1007/s40121-023-00778-1 |
_version_ | 1785034879231066112 |
---|---|
author | Herrera-Restrepo, Oscar Clements, Diana E. Conley, Wanda J. Marshall, Gary S. |
author_facet | Herrera-Restrepo, Oscar Clements, Diana E. Conley, Wanda J. Marshall, Gary S. |
author_sort | Herrera-Restrepo, Oscar |
collection | PubMed |
description | Patients with functional or anatomic asplenia, including sickle cell anemia; complement component deficiency; or human immunodeficiency virus (HIV) infection have a significantly increased risk of developing meningococcal disease. The Advisory Committee on Immunization Practices (ACIP) of the Centers for Disease Control and Prevention (CDC) recommends vaccination with a quadrivalent meningococcal conjugate vaccine against serogroups A, C, W, and Y (MenACWY) for individuals 2 months of age or older who are diagnosed with functional or anatomic asplenia, complement component deficiency, or HIV infection. Vaccination with a meningococcal vaccine against serogroup B (MenB) is also recommended for individuals 10 years of age or older who are diagnosed with functional or anatomic asplenia or complement component deficiency. Despite these recommendations, recent studies have shown that vaccination coverage in these populations is low. In this podcast, the authors discuss the challenges for implementing vaccine recommendations for individuals with medical conditions at increased risk of developing meningococcal disease and discuss strategies to increase coverage. Suboptimal vaccination rates could be addressed by better educating healthcare providers about recommendations for MenACWY and MenB vaccines in individuals at increased risk, increasing awareness of low vaccination coverage, and tailoring the education to the needs of particular healthcare providers and their respective patient populations. Barriers to vaccination could also be removed by administering vaccines at alternative sites of care, bundling preventative services, and implementing vaccination reminder systems that are tied to immunization information systems. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s40121-023-00778-1) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-10147888 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer Healthcare |
record_format | MEDLINE/PubMed |
spelling | pubmed-101478882023-04-30 Expert Perspectives on the Vaccination of Individuals Who Are at Increased Risk of Meningococcal Disease Due to Medical Conditions: A Podcast Herrera-Restrepo, Oscar Clements, Diana E. Conley, Wanda J. Marshall, Gary S. Infect Dis Ther Commentary Patients with functional or anatomic asplenia, including sickle cell anemia; complement component deficiency; or human immunodeficiency virus (HIV) infection have a significantly increased risk of developing meningococcal disease. The Advisory Committee on Immunization Practices (ACIP) of the Centers for Disease Control and Prevention (CDC) recommends vaccination with a quadrivalent meningococcal conjugate vaccine against serogroups A, C, W, and Y (MenACWY) for individuals 2 months of age or older who are diagnosed with functional or anatomic asplenia, complement component deficiency, or HIV infection. Vaccination with a meningococcal vaccine against serogroup B (MenB) is also recommended for individuals 10 years of age or older who are diagnosed with functional or anatomic asplenia or complement component deficiency. Despite these recommendations, recent studies have shown that vaccination coverage in these populations is low. In this podcast, the authors discuss the challenges for implementing vaccine recommendations for individuals with medical conditions at increased risk of developing meningococcal disease and discuss strategies to increase coverage. Suboptimal vaccination rates could be addressed by better educating healthcare providers about recommendations for MenACWY and MenB vaccines in individuals at increased risk, increasing awareness of low vaccination coverage, and tailoring the education to the needs of particular healthcare providers and their respective patient populations. Barriers to vaccination could also be removed by administering vaccines at alternative sites of care, bundling preventative services, and implementing vaccination reminder systems that are tied to immunization information systems. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s40121-023-00778-1) contains supplementary material, which is available to authorized users. Springer Healthcare 2023-03-13 2023-04 /pmc/articles/PMC10147888/ /pubmed/36913178 http://dx.doi.org/10.1007/s40121-023-00778-1 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Commentary Herrera-Restrepo, Oscar Clements, Diana E. Conley, Wanda J. Marshall, Gary S. Expert Perspectives on the Vaccination of Individuals Who Are at Increased Risk of Meningococcal Disease Due to Medical Conditions: A Podcast |
title | Expert Perspectives on the Vaccination of Individuals Who Are at Increased Risk of Meningococcal Disease Due to Medical Conditions: A Podcast |
title_full | Expert Perspectives on the Vaccination of Individuals Who Are at Increased Risk of Meningococcal Disease Due to Medical Conditions: A Podcast |
title_fullStr | Expert Perspectives on the Vaccination of Individuals Who Are at Increased Risk of Meningococcal Disease Due to Medical Conditions: A Podcast |
title_full_unstemmed | Expert Perspectives on the Vaccination of Individuals Who Are at Increased Risk of Meningococcal Disease Due to Medical Conditions: A Podcast |
title_short | Expert Perspectives on the Vaccination of Individuals Who Are at Increased Risk of Meningococcal Disease Due to Medical Conditions: A Podcast |
title_sort | expert perspectives on the vaccination of individuals who are at increased risk of meningococcal disease due to medical conditions: a podcast |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10147888/ https://www.ncbi.nlm.nih.gov/pubmed/36913178 http://dx.doi.org/10.1007/s40121-023-00778-1 |
work_keys_str_mv | AT herrerarestrepooscar expertperspectivesonthevaccinationofindividualswhoareatincreasedriskofmeningococcaldiseaseduetomedicalconditionsapodcast AT clementsdianae expertperspectivesonthevaccinationofindividualswhoareatincreasedriskofmeningococcaldiseaseduetomedicalconditionsapodcast AT conleywandaj expertperspectivesonthevaccinationofindividualswhoareatincreasedriskofmeningococcaldiseaseduetomedicalconditionsapodcast AT marshallgarys expertperspectivesonthevaccinationofindividualswhoareatincreasedriskofmeningococcaldiseaseduetomedicalconditionsapodcast |